Testing dark vision changes as a statin response signal
Treatments studied
Part of Eyes & vision clinical trials.
This Phase 2 study looks at whether changes in night/dark adaptation can show early whether high-dose atorvastatin (a statin) is helping intermediate age-related macular degeneration (AMD). If you fit, you may help researchers find an earlier way to tell who is responding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have intermediate AMD (in at least one eye)
- Your study eye has “high-risk” intermediate AMD features (a specific drusen pattern) and no known GA (advanced atrophy) or CNV (abnormal vessel growth) in that study eye
- You have not taken high-dose atorvastatin 80 mg before
- You have not previously used other statins that your doctor says cannot safely be changed to high-dose atorvastatin
- You do not have a prior bad reaction to statins
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to track changes in the eyes of people with early or intermediate age-related macular degeneration (AMD). It aims to better understand how the disease progresses and may help doctors personalize care.
This trial uses artificial intelligence to track changes in the eyes of people with advanced age-related macular degeneration (AMD) that has caused a specific type of damage (atrophy) in the retina. The goal is to see if AI can help detect when the disease gets worse, so doctors can personalize monitoring for each patient.
This study collects immune cells (from a blood sample) from people with certain types of age-related macular degeneration (AMD) and compares how long they live. It may help researchers understand how immune-related changes relate to AMD outcomes.
This study looks at how age-related macular degeneration (AMD) affects daily activities. If you have AMD and your vision is at least 4/10, you may be able to join to help researchers understand the impact on everyday life.
This study tracks how age-related macular degeneration (AMD) progresses over time and looks at factors that might affect your vision and quality of life. By participating, you'll help researchers understand more about AMD and what might predict better or worse outcomes.
This study tests a new treatment to improve vision in people with advanced age-related macular degeneration (AMD). If you have significant vision loss from AMD, this might help you see better.
Hear when a new Age-Related Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.